1-13 of 13
David C. Christiani
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Common TDP1 Polymorphisms in Relation to Survival among Small Cell Lung Cancer Patients: A Multicenter Study from the International Lung Cancer Consortium

Free
Pawadee Lohavanichbutr, Lori C. Sakoda, Christopher I. Amos, Susanne M. Arnold, David C. Christiani, Michael P.A. Davies, John K. Field, Eric B. Haura, Rayjean J. Hung, Takashi Kohno, Maria Teresa Landi, Geoffrey Liu, Yi Liu, Michael W. Marcus, Grainne M. O'Kane, Matthew B. Schabath, Kouya Shiraishi, Stacey A. Slone, Adonina Tardón, Ping Yang, Kazushi Yoshida, Ruyang Zhang, Xuchen Zong, Gary E. Goodman, Noel S. Weiss, Chu Chen
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (24): 7550–7557.
https://doi.org/10.1158/1078-0432.CCR-17-1401
Published: 14 December 2017
View articletitled, Common TDP1 Polymorphisms in Relation to Survival among Small Cell Lung Cancer Patients: A Multicenter Study from the International Lung Cancer Consortium
Open the PDF for Common TDP1 Polymorphisms in Relation to Survival among Small Cell Lung Cancer Patients: A Multicenter Study from the International Lung Cancer Consortium in another window
Includes: Supplementary data
Journal Articles

Abstract NTOC-110: UNEXPECTED ROLES FOR KDM4A: PROTEIN SYNTHESIS AND MTOR INHIBITOR SENSITIVITY

Free
Capucine Van Rechem, Joshua C. Black, Patricia Greninger, Yang Zhao, Myriam Boukhali, Carlos Donado, Martin J. Aryee, Paul d. Burrowes, Brendon Ladd, Susanne Gräslund, Wilhelm Haas, David C. Christiani, Cyril H. Benes, Johnathan R. Whetstine
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (11_Supplement): NTOC-110.
https://doi.org/10.1158/1557-3265.OVCASYMP16-NTOC-110
Published: 31 May 2017
View articletitled, Abstract NTOC-110: UNEXPECTED ROLES FOR KDM4A: PROTEIN SYNTHESIS AND MTOR INHIBITOR SENSITIVITY
Journal Articles

Circulating Oncometabolite 2-Hydroxyglutarate Is a Potential Surrogate Biomarker in Patients with Isocitrate Dehydrogenase-Mutant Intrahepatic Cholangiocarcinoma

Free
Darrell R. Borger, Lipika Goyal, Thomas Yau, Ronnie T. Poon, Marek Ancukiewicz, Vikram Deshpande, David C. Christiani, Hannah M. Liebman, Hua Yang, Hyeryun Kim, Katharine Yen, Jason E. Faris, A. John Iafrate, Eunice L. Kwak, Jeffrey W. Clark, Jill N. Allen, Lawrence S. Blaszkowsky, Janet E. Murphy, Supriya K. Saha, Theodore S. Hong, Jennifer Y. Wo, Cristina R. Ferrone, Kenneth K. Tanabe, Nabeel Bardeesy, Kimberly S. Straley, Sam Agresta, David P. Schenkein, Leif W. Ellisen, David P. Ryan, Andrew X. Zhu
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (7): 1884–1890.
https://doi.org/10.1158/1078-0432.CCR-13-2649
Published: 31 March 2014
View articletitled, Circulating Oncometabolite 2-Hydroxyglutarate Is a Potential Surrogate Biomarker in Patients with Isocitrate Dehydrogenase-Mutant Intrahepatic Cholangiocarcinoma
Open the PDF for Circulating Oncometabolite 2-Hydroxyglutarate Is a Potential Surrogate Biomarker in Patients with Isocitrate Dehydrogenase-Mutant Intrahepatic Cholangiocarcinoma in another window
Includes: Supplementary data
Journal Articles

Genome-Wide Association Study of Prognosis in Advanced Non–Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy

Free
Lingmin Hu, Chen Wu, Xueying Zhao, Rebecca Heist, Li Su, Yang Zhao, Baohui Han, Songyu Cao, Minjie Chu, Juncheng Dai, Jing Dong, Yongqian Shu, Lin Xu, Yijiang Chen, Yi Wang, Feng Lu, Yue Jiang, Dianke Yu, Hongyan Chen, Wen Tan, Hongxia Ma, Jiaping Chen, Guangfu Jin, Tangchun Wu, Daru Lu, David C. Christiani, Dongxin Lin, Zhibin Hu, Hongbing Shen
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (19): 5507–5514.
https://doi.org/10.1158/1078-0432.CCR-12-1202
Published: 30 September 2012
View articletitled, Genome-Wide Association Study of Prognosis in Advanced Non–Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy
Open the PDF for Genome-Wide Association Study of Prognosis in Advanced Non–Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy in another window
Includes: Supplementary data
Journal Articles

p53 Arg72Pro and MDM2 T309G Polymorphisms, Histology, and Esophageal Cancer Prognosis

Free
David W. Cescon, Penelope A. Bradbury, Kofi Asomaning, Jessica Hopkins, Rihong Zhai, Wei Zhou, Zhaoxi Wang, Matthew Kulke, Li Su, Clement Ma, Wei Xu, Ariela L. Marshall, Rebecca Suk Heist, John C. Wain, Thomas J. Lynch, Jr., David C. Christiani, Geoffrey Liu
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (9): 3103–3109.
https://doi.org/10.1158/1078-0432.CCR-08-3120
Published: 30 April 2009
View articletitled, p53 Arg72Pro and MDM2 T309G Polymorphisms, Histology, and Esophageal Cancer Prognosis
Open the PDF for p53 Arg72Pro and MDM2 T309G Polymorphisms, Histology, and Esophageal Cancer Prognosis in another window
Journal Articles

Lung Cancer Genetics: A Family Affair?

Free
David C. Christiani
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (8): 2581–2582.
https://doi.org/10.1158/1078-0432.CCR-09-0003
Published: 15 April 2009
View articletitled, Lung Cancer Genetics: A Family Affair?
Open the PDF for Lung Cancer Genetics: A Family Affair? in another window
Includes: Supplementary data
Journal Articles

MDM2 Promoter Polymorphism and Pancreatic Cancer Risk and Prognosis

Free
Kofi Asomaning, Amy E. Reid, Wei Zhou, Rebecca S. Heist, Rihong Zhai, Li Su, Eunice L. Kwak, Lawrence Blaszkowsky, Andrew X. Zhu, David P. Ryan, David C. Christiani, Geoffrey Liu
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (12): 4010–4015.
https://doi.org/10.1158/1078-0432.CCR-07-4187
Published: 16 June 2008
View articletitled, MDM2 Promoter Polymorphism and Pancreatic Cancer Risk and Prognosis
Open the PDF for MDM2 Promoter Polymorphism and Pancreatic Cancer Risk and Prognosis in another window
Journal Articles

A Functional Epidermal Growth Factor (EGF) Polymorphism, EGF Serum Levels, and Esophageal Adenocarcinoma Risk and Outcome

Free
Michael Lanuti, Geoffrey Liu, Jonathan M. Goodwin, Rihong Zhai, Bryan C. Fuchs, Kofi Asomaning, Li Su, Norman S. Nishioka, Kenneth K. Tanabe, David C. Christiani
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (10): 3216–3222.
https://doi.org/10.1158/1078-0432.CCR-07-4932
Published: 15 May 2008
View articletitled, A Functional Epidermal Growth Factor (EGF) Polymorphism, EGF Serum Levels, and Esophageal Adenocarcinoma Risk and Outcome
Open the PDF for A Functional Epidermal Growth Factor (EGF) Polymorphism, EGF Serum Levels, and Esophageal Adenocarcinoma Risk and Outcome in another window
Journal Articles

Vascular Endothelial Growth Factor Genotypes, Haplotypes, Gender, and the Risk of Non–Small Cell Lung Cancer

Free
Rihong Zhai, Geoffrey Liu, Wei Zhou, Li Su, Rebecca Suk Heist, Thomas J. Lynch, John C. Wain, Kofi Asomaning, Xihong Lin, David C. Christiani
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (2): 612–617.
https://doi.org/10.1158/1078-0432.CCR-07-1655
Published: 25 January 2008
View articletitled, Vascular Endothelial Growth Factor Genotypes, Haplotypes, Gender, and the Risk of Non–Small Cell Lung Cancer
Open the PDF for Vascular Endothelial Growth Factor Genotypes, Haplotypes, Gender, and the Risk of Non–Small Cell Lung Cancer in another window
Journal Articles

Second Hand Smoke Exposure and Survival in Early-Stage Non–Small-Cell Lung Cancer Patients

Free
Wei Zhou, Rebecca S. Heist, Geoffrey Liu, Kofi Asomaning, David P. Miller, Donna S. Neuberg, John C. Wain, Thomas J. Lynch, David C. Christiani
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (23): 7187–7193.
https://doi.org/10.1158/1078-0432.CCR-06-1460
Published: 04 December 2006
View articletitled, Second Hand Smoke Exposure and Survival in Early-Stage Non–Small-Cell Lung Cancer Patients
Open the PDF for Second Hand Smoke Exposure and Survival in Early-Stage Non–Small-Cell Lung Cancer Patients in another window
Journal Articles

Matrix Metalloproteinase Polymorphisms and Survival in Stage I Non–Small Cell Lung Cancer

Free
Rebecca Suk Heist, Ariela L. Marshall, Geoffrey Liu, Wei Zhou, Li Su, Donna Neuberg, Thomas J. Lynch, John Wain, David C. Christiani
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (18): 5448–5453.
https://doi.org/10.1158/1078-0432.CCR-06-0262
Published: 25 September 2006
View articletitled, Matrix Metalloproteinase Polymorphisms and Survival in Stage I Non–Small Cell Lung Cancer
Open the PDF for Matrix Metalloproteinase Polymorphisms and Survival in Stage I Non–Small Cell Lung Cancer in another window
Journal Articles

Polymorphisms in ERCC1 and Grade 3 or 4 Toxicity in Non–Small Cell Lung Cancer Patients

Free
Rebecca Suk, Sarada Gurubhagavatula, Sohee Park, Wei Zhou, Li Su, Thomas J. Lynch, John C. Wain, Donna Neuberg, Geoffrey Liu, David C. Christiani
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (4): 1534–1538.
https://doi.org/10.1158/1078-0432.CCR-04-1953
Published: 02 March 2005
View articletitled, Polymorphisms in ERCC1 and Grade 3 or 4 Toxicity in Non–Small Cell Lung Cancer Patients
Open the PDF for Polymorphisms in ERCC1 and Grade 3 or 4 Toxicity in Non–Small Cell Lung Cancer Patients in another window
Journal Articles

Excision Repair Cross-Complementation Group 1 Polymorphism Predicts Overall Survival in Advanced Non-Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy

Free
Wei Zhou, Sarada Gurubhagavatula, Geoffrey Liu, Sohee Park, Donna S. Neuberg, John C. Wain, Thomas J. Lynch, Li Su, David C. Christiani
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (15): 4939–4943.
https://doi.org/10.1158/1078-0432.CCR-04-0247
Published: 05 August 2004
View articletitled, Excision Repair Cross-Complementation Group 1 Polymorphism Predicts Overall Survival in Advanced Non-Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy
Open the PDF for Excision Repair Cross-Complementation Group 1 Polymorphism Predicts Overall Survival in Advanced Non-Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy in another window